3D Cell Culture Market worth $2.5 billion by 2028
The report "3D Cell Culture Market by Product (Hydrogels, ECM, Hanging Drop, Bioreactor, Microfluidics, Magnetic Levitation), Application (Cancer, Stem Cell, Tissue Engineering), End User (Pharma, Biotech, Research), Region - Global Forecast to 2028 ", size is projected to reach 2.5 billion by 2028 from 1.3 in 2023, at a CAGR of 14.6% during the forecast period. Major factors driving the market growth at significant CAGR are increasing adoption of 3D cell culture over, restrictions over animal testing and increased use of 3D cell culture in personalized medicine.
Browse 205 market data Tables and 39 Figures spread through 244 Pages and in-depth TOC on "3D Cell Culture Market by Product (Hydrogels, ECM, Hanging Drop, Bioreactor, Microfluidics, Magnetic Levitation), Application (Cancer, Stem Cell, Tissue Engineering), End User (Pharma, Biotech, Research), Region - Global Forecast to 2028 "
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/3d-cell-culture-market-191072847.html
Scaffold-based 3D cell culture accounted for the largest share of the product segment in the 3D cell culture market in 2022.
Based on product, the 3D cell culture market is segmented into scaffold-based 3D cell cultures, scaffold-free 3D cell cultures, microfluidics-based 3D cell cultures, and magnetic & bioprinted 3D cell cultures. The scaffold-based 3D cell cultures segment accounted for the largest share in 2022. The advantages of scaffolds in 3D cell cultures, such as structural rigidity, the availability of attachment points, and support, have greatly driven the preference for the segment and ensured its large share in the market.
The cancer & stem cell segment research segment accounted for the largest share of the application segment in the 3D cell culture market in 2022.
Based on application, the market is segmented into cancer & stem cell research, drug discovery & toxicology testing, and tissue engineering & regenerative medicine. Cancer & stem cell segment research accounted for the largest market share of the market in 2022. The increasing prevalence of cancer and significant funding initiatives for cancer research from the government and the private sector are major factors driving the growth of this application segment..
Asia Pacific is likely to grow at the highest growth rate during the forecast period.
Based on region, the 3D cell culture market is segmented into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. In 2022, North America dominated the market, followed by Europe. The increasing incidence of cancer and a well-established pharmaceutical & biotechnology industry are key factors supporting the growth of the North American 3D cell culture market. The Asia Pacific market is projected to grow at the highest CAGR of 16.0% during the forecast period. Most companies in the market focus on organic and inorganic growth strategies, such as product launches, expansions, acquisitions, partnerships, agreements, and collaborations, to increase their product offerings, cater to the unmet needs of customers, increase their profitability, and expand their presence in the global market.
The 3D cell culture market is consolidated, with a small number of players competing for market shares. Thermo Fisher Scientific. Inc. (US), Merck KGaA (Germany), Corning Incorporated (US), Lonza (Switzerland), and Avantor Inc. (US) are some of the leading players in this market.
English
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Romaian